Zhigang Tu (Z Tu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 10

Top Venues

British journal of cancer

Clinical and experimental pharmacology & physiology

Cell death & disease

Cellular and molecular life sciences : CMLS

Jiangsu University

Stevens Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jiangsu University

China

Professor :: Institute of Life Sciences

Wistar Institute

United States

Associate Staff Scientist

Fox Chase Cancer Center

United States

Postdoctoral Associate

Education History

Stevens Institute of Technology

United States

PHD

Nanjing University

China

MSC

Nanjing University and China Pharmaceutical University

China

BSC

Publications

Lipeng Qiu, Ruyan Li, Yue Wang, Ziwen Lu, Zhigang Tu, Hanqing Liu
PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex. British journal of cancer 131 (3) (2024)
Lipeng Qiu, Ruyan Li, Yue Wang, Ziwen Lu, Zhigang Tu, Hanqing Liu
PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex. British journal of cancer (2024)
Lipeng Qiu, Ruyan Li, Yue Wang, Ziwen Lu, Zhigang Tu, Hanqing Liu
PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex. British journal of cancer 131 (3) (2024)
Lipeng Qiu, Ruyan Li, Yue Wang, Ziwen Lu, Zhigang Tu, Hanqing Liu
PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex. British journal of cancer 131 (3) (2024)
Dongsheng Shang, Tianchu Zhou, Xinying Zhuang, Yanfang Wu, Hanqing Liu, Zhigang Tu
Molecular dissection on inhibition of Ras-induced cellular senescence by small t antigen of SV40. Cellular and molecular life sciences : CMLS 79 (5) (2022)
Ziwen Lu, Sirui Yuan, Lingling Ruan, Zhigang Tu, Hanqing Liu
Partitioning defective 6 homolog alpha (PARD6A) promotes epithelial-mesenchymal transition via integrin β1-ILK-SNAIL1 pathway in ovarian cancer. Cell death & disease 13 (4) (2022)
Dongsheng Shang, Danlin Sun, Chunyan Shi, Jun Xu, Mingxiang Shen, Xing Hu, Hanqing Liu, Zhigang Tu
Activation of epidermal growth factor receptor signaling mediates cellular senescence induced by certain pro-inflammatory cytokines. Aging cell 19 (5) (2020)
Yanting Shen, Lingling Ruan, Caixia Lian, Ruyan Li, Zhigang Tu, Hanqing Liu
Discovery of HB-EGF binding peptides and their functional characterization in ovarian cancer cell lines. Cell death discovery 5 (2019)
Lingling Ruan, Yanting Shen, Ziwen Lu, Dongsheng Shang, Zhicong Zhao, Yongjin Lu, Yanfang Wu, Yafei Zhang, Zhigang Tu, Hanqing Liu
Roles of partitioning-defective protein 6 (Par6) and its complexes in the proliferation, migration and invasion of cancer cells. Clinical and experimental pharmacology & physiology 44 (9) (2018)
Dongsheng Shang, Yanfang Wu, Ya Ding, Ziwen Lu, Yanting Shen, Feifei Zhu, Hanqing Liu, Chunyin Zhu, Zhigang Tu
Identification of a pyridine derivative inducing senescence in ovarian cancer cell lines via P21 activation. Clinical and experimental pharmacology & physiology 45 (5) (2017)
Hanqing Liu, J Lu, Y Hua, P Zhang, Z Liang, L Ruan, C Lian, H Shi, K Chen, Zhigang Tu
Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer. Cell death & disease 6 (2015)

Zhigang Tu.css-eqlu8i{font-size:small;padding-left:4px;} (Z Tu)

Publication Activity (10 Years)

Top Topics

Top Venues

Zhigang Tu (Z Tu)